Galecto Inc

-0.16 (-2.91%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Galecto Inc Stock, NASDAQ:GLTO

Ole Maaloes Vej 3, Copenhagen, Capital Region 2200
Phone: +
Number of Employees: 28


Galecto, Inc. operates as a clinical-stage biotechnology company developing therapeutics which are designed to target the biological processes to treat fibrotic and related diseases including cancer. Its product portfolio includes GB0139, GB1211, GB2064, and GB1211. The company was founded by Ulf Nilsson, Hakon Leffler, Tariq Sethi, and Hans T. Schambye in 2011 and is headquartered in Copenhagen, Denmark.